CSI Market
Sign In | Register

Purple Biotech Ltd (PPBT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PPBT Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Purple Biotech Ltd's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) 0 0 0
Assets
Cash And Cash Equivalents8.72
Cash & Short-term Investments8.00
Notes Receivable, Current0.01
Other Current Assets0.00
Total Current Assets9.87
Equipment/Property/Plant Net0.12
Intangible Assets7.36
Other Assets, Noncurrent1.37
Total Assets17.57
Liabilities
Other Liabilities, Current0.00
Total Current Liabilities7.75
Total Long-term Debt0.00
Total Liabilities7.91
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity9.66
Total Stockholder's Equity9.66
Liabilities & Stockholder's Equity17.57
4 historic quarters locked

Sign in to unlock the full Purple Biotech Ltd balance sheet history.

Sign In Create Free Account

About Purple Biotech Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-031365

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.